Cost-effectiveness of treatment in adults with blood pressure of 130–139/80–89 mmHg and high cardiovascular risk in China: a modelling study

BACKGROUND: The most recent updated hypertension guidelines recommend individuals with systolic blood pressure (SBP)/diastolic blood pressure (DBP) of 130–139/80–89 mmHg and high cardiovascular risk should receive antihypertensive drug treatment. This study aimed to assess the benefits and cost-effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiangtao, Zhao, Dong, Cai, Jun, Chen, Shuohua, Wu, Shouling, Qi, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689267/
https://www.ncbi.nlm.nih.gov/pubmed/38045985
http://dx.doi.org/10.1016/j.lanwpc.2023.100962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689267/
https://www.ncbi.nlm.nih.gov/pubmed/38045985
http://dx.doi.org/10.1016/j.lanwpc.2023.100962

Ejemplares similares